1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells.
(
- Contribution to journal › Article
- 2009
-
Mark
High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer.
(
- Contribution to journal › Article
- 2005
-
Mark
Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project
(
- Contribution to journal › Article
- 2000
-
Mark
Expression and characterization of trypsinogen produced in the human male genital tract
(
- Contribution to journal › Article
-
Mark
Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissues
(
- Contribution to journal › Article
-
Mark
New nomenclature for the human tissue kallikrein gene family
(
- Contribution to journal › Article
- 1999
-
Mark
Reactivity of anti-PSA monoclonal antibodies with recombinant human kallikrein-2
(
- Contribution to journal › Article
-
Mark
Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specific antigen
(
- Contribution to journal › Article
- 1994
-
Mark
Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993
(
- Contribution to journal › Article